The Effectiveness of Anti-Interleukin-17A Treatment for Pityriasis Rubra Pilaris: A Systematic Review

Anti-interleukin-17A (anti-IL-17A) therapy has been increasingly employed as a treatment option for pityriasis rubra pilaris (PRP). In this study, we reviewed all available studies on this topic in the literature to evaluate the efficacy and safety of anti-IL-17A. Our main objective was to assess th...

Descripción completa

Detalles Bibliográficos
Autores principales: Abduljawad, Mohammad, Alsharif, Thamer H, Gronfula, Amin G, Magadmi, Talah K, Khayat, Lujain I, Fageeh, Sarah M, Almuallim, Abdulqader A, Mohammad, Mohammad Ayman, Albadri, Abdullah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382908/
https://www.ncbi.nlm.nih.gov/pubmed/37519579
http://dx.doi.org/10.7759/cureus.41125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382908/
https://www.ncbi.nlm.nih.gov/pubmed/37519579
http://dx.doi.org/10.7759/cureus.41125

Ejemplares similares